Prime Capital Investment Advisors LLC Sells 1,732 Shares of CME Group Inc. $CME

Prime Capital Investment Advisors LLC decreased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 21.6% during the 2nd quarter, Holdings Channel reports. The firm owned 6,278 shares of the financial services provider’s stock after selling 1,732 shares during the quarter. Prime Capital Investment Advisors LLC’s holdings in CME Group were worth $1,730,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in CME. Farther Finance Advisors LLC boosted its position in shares of CME Group by 11.4% during the 1st quarter. Farther Finance Advisors LLC now owns 5,506 shares of the financial services provider’s stock valued at $1,444,000 after purchasing an additional 563 shares in the last quarter. Wealthcare Advisory Partners LLC raised its stake in CME Group by 3.6% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider’s stock worth $356,000 after buying an additional 47 shares during the period. GAMMA Investing LLC raised its stake in CME Group by 24.5% during the 1st quarter. GAMMA Investing LLC now owns 7,007 shares of the financial services provider’s stock worth $1,859,000 after buying an additional 1,381 shares during the period. Assenagon Asset Management S.A. raised its stake in CME Group by 649.6% during the 1st quarter. Assenagon Asset Management S.A. now owns 113,836 shares of the financial services provider’s stock worth $30,200,000 after buying an additional 98,650 shares during the period. Finally, CX Institutional raised its stake in CME Group by 10.1% during the 1st quarter. CX Institutional now owns 2,876 shares of the financial services provider’s stock worth $763,000 after buying an additional 265 shares during the period. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME Group stock opened at $264.94 on Thursday. The company has a market cap of $95.48 billion, a PE ratio of 25.65, a price-to-earnings-growth ratio of 5.56 and a beta of 0.41. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79. The business has a 50 day moving average price of $269.26 and a 200-day moving average price of $271.06. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the business posted $2.56 earnings per share. Equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 48.40%.

Wall Street Analyst Weigh In

CME has been the topic of a number of research reports. Weiss Ratings reaffirmed a “buy (b)” rating on shares of CME Group in a research note on Wednesday. JPMorgan Chase & Co. upped their price target on CME Group from $246.00 to $252.00 and gave the stock an “underweight” rating in a research note on Thursday, September 25th. Barclays dropped their price target on CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Morgan Stanley upped their price target on CME Group from $303.00 to $312.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 1st. Finally, Piper Sandler upped their price target on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 15th. Six equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average price target of $275.17.

Insiders Place Their Bets

In related news, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the sale, the general counsel directly owned 7,851 shares of the company’s stock, valued at $2,056,962. The trade was a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,043 shares of company stock valued at $3,527,956. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.